Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Astrazeneca Pharma India Ltd.
BSE Code 506820
ISIN Demat INE203A01020
Book Value 319.60
NSE Code ASTRAZEN
Dividend Yield % 0.35
Market Cap 225958.75
P/E 113.46
EPS 79.66
Face Value 2  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
26-Dec-2025 9162.75 9162.75 8820.35 8908.70 389 3497016
24-Dec-2025 9145.00 9180.00 9079.35 9162.75 51 466322
23-Dec-2025 8950.05 9163.90 8950.05 9116.20 150 1369117
22-Dec-2025 9093.95 9147.90 9066.70 9122.55 67 610398
19-Dec-2025 9074.55 9165.90 9048.00 9062.25 165 1502386
18-Dec-2025 9090.00 9098.75 8950.00 9074.55 235 2124702
17-Dec-2025 8950.20 9057.40 8950.20 9025.80 57 513568
16-Dec-2025 9070.00 9081.50 8991.60 9011.85 88 794611
15-Dec-2025 9139.40 9182.05 9087.40 9124.55 118 1078853
12-Dec-2025 9184.10 9197.90 9104.00 9138.35 103 941662
11-Dec-2025 9097.85 9240.00 8938.85 9145.45 374 3417186
10-Dec-2025 9045.00 9101.65 8994.45 9014.05 108 976236
09-Dec-2025 9013.05 9140.00 8940.00 9026.25 418 3771491
08-Dec-2025 9255.00 9255.00 8982.00 9021.60 155 1413532
05-Dec-2025 9136.00 9230.50 9108.00 9211.50 70 643436
04-Dec-2025 9089.80 9240.00 9089.80 9188.90 187 1708905
03-Dec-2025 9140.20 9148.20 9072.10 9089.00 79 719456
02-Dec-2025 9084.10 9160.00 8993.60 9140.85 518 4697475
01-Dec-2025 9010.00 9085.00 8997.60 9054.00 357 3228222
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.